About
Device Access UK
Device Access has supported a wide range of international and European companies introducing high value medical technologies to the UK, effectively navigating the complex NHS reimbursement pathways through the creation and implementation of local and national market access strategies that demonstrate the technologies’ true value.
In 2017, Device Access became one of the first NICE approved facilitators for the MedTech Early Technical Assessment (META Tool®).
Device Access holds a data sharing agreement from NHS England, which provides data on all hospital admissions and outcomes on a monthly basis, allowing them to work with companies to further understand the impact technologies may have on current patient populations.
AiM supports the medical device industry in accessing the German-speaking markets in Europe. AiM is a specialist for all questions regarding market access, reimbursement and pricing in Germany, Austria and Switzerland. The focus is on identifying the right reimbursement pathways in the outpatient and inpatient sector.
Since its foundation in 2007, AiM has successfully completed more than 800 projects for more than 250 clients.
AiM is based in Lörrach, Germany.
Highly specialized, and with a lot of enthusiasm, Meditech Access helps medical device innovators to enter the French-speaking markets. Meditech Access' particular strength is the development of sustainable concepts that give companies security and ensure that patients are quickly provided with valuable medical technology innovations.
Meditech Access was founded in 2012. A large number of projects have been successfully implemented since then. Today, Meditech Access is recognized as a powerful provider of market access solutions for France.
Meditech Access is based in Versailles, France.
For the full IGES MedTech portfolio please visit the MedTech Website.
Prof. Dr. Bertram Häussler, Chairman of the IGES Institute. He is a physician, sociologist and honorary professor for economics of the pharmaceutical industry at the Technical University (TU) Berlin. His research focuses on health economics, health technology assessment in a national and international context, and digitization of health care systems.
John is an experienced healthcare leader with a strong background in NHS market access and MedTech adoption. With senior roles across multiple NHS Trusts, he has led service transformations in trauma, surgery, and emergency care, focusing on optimising hospital operations, care pathways, and financial performance.
Before joining Device Access, John was CEO of Pellerehealth Ltd, providing strategic consultancy to global MedTech firms on NHS engagement, reimbursement pathways, and market adoption strategies. His deep understanding of NHS procurement and policy landscapes makes him a key partner for companies looking to accelerate market entry in the UK healthcare system.
At Device Access, John works closely with MedTech innovators to develop compelling value propositions, navigate NHS reimbursement frameworks, and ensure that groundbreaking technologies reach the patients who need them most.
Debbie has over 17 years experience in the NHS as a Service Improvement Manager. During her tenure she took a diploma in Innovations and Change Management and subsequently established, led and delivered a sustainable NHS innovation pathway from concept to commercialisation.
Debbie works closely with companies to develop business dossiers that support local and national market adoption of new technologies by the NHS.
Jowan runs and maintains the SQL database that continuously contains 4 years of NHS Digital hospital episode statistics. This involves managing over 1 billion data points relating to admitted patient care, accident and emergency, critical care and outpatient tables.
Jowan works with companies to provide in-depth analysis for specific patient cohorts from the hospital episode statistics.
Mehdi has over 13 years experience in market access and reimbursement and has produced over 50 economic evaluation models (CAE, CUA, Budget impact analyses) in different disease areas including cardiovascular, oncology, diabetes, ophthalmology, urology and otorhinolaryngology. Mehdi has also had over 80 publications accepted by high impact journals.
Mehdi works closely with NICE and is currently a senior advisor within the Research Design Service and a member of the Evidence Review Group.
You can find Mehdi’s publications here.
